Want to see JP:4506 full AI Analyst Report?
Sumitomo Dainippon Pharma Co (4506) Income Statement
Sumitomo Dainippon Pharma Co Income Statement
Last quarter (Q3 2026), Sumitomo Dainippon Pharma Co's total revenue was $120.62B, a decrease of 6.85% from the same quarter last year. In Q3, Sumitomo Dainippon Pharma Co's net income was $8.82B. See Sumitomo Dainippon Pharma Co’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|---|---|
| $ 398.83B | $ 453.29B | $ 314.56B | $ 555.54B | $ 560.03B | |
| $ 225.38B | $ 256.89B | $ 157.08B | $ 342.95B | $ 371.18B | |
| $ 202.96B | $ 206.55B | $ 158.55B | $ 331.74B | $ 314.62B | |
| Depreciation and Amortization | $ 25.56B | $ 20.79B | $ 37.77B | $ 41.26B | $ 38.35B |
| $ 51.73B | $ 131.32B | $ -281.07B | $ -3.50B | $ 124.36B | |
| $ 22.42B | $ 50.34B | $ -1.48B | $ 11.20B | $ 56.55B | |
| $ -4.81B | $ 50.00B | $ -321.64B | $ -59.12B | $ 26.41B | |
| $ 17.61B | $ 100.34B | $ -323.11B | $ -47.92B | $ 82.96B | |
| $ 23.63B | $ 106.86B | $ -314.97B | $ -74.51B | $ 56.41B | |
| Per Share Metrics | |||||
| Basic EPS | $ 59.49 | $ 268.99 | $ -792.79 | $ -187.55 | $ 141.99 |
| Diluted EPS | $ 59.49 | $ 268.99 | $ -792.79 | $ -187.55 | $ 141.99 |
| Weighted Average Shares Outstanding | 397.29M | 397.29M | 397.29M | 397.29M | 397.29M |
| Weighted Average Shares Outstanding (Diluted) | 397.29M | 397.29M | 397.29M | 397.29M | 397.29M |
Currency in JPY
